Beyond Analgesia: Evaluating the Chondroprotective Potential of Extracorporeal Shockwave Therapy in Knee Osteoarthritis
PM&R · 2026-11 · 18 (S3)
DOI: 10.1002/pmrj.68_70259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Suha Qasem und 1 weiteren Autor:innen.
Abstract (Originalsprache)
registry of 1,067 patient cases between January 2019 and January 2025.
Setting
Specialized outpatient regenerative sports medicine center.
Participants
From a 2019-2025 registry, 1,067 adults receiving PRP or BMAC were analyzed.Excluding incomplete records, participants were stratified by BMI (Normal, Overweight, Obese) and assessed at ≥6 months.Analysis adjusted for age, sex, and tobacco use.
Interventions
Participants received ultrasound-guided injections of either Platelet-Rich Plasma, prepared via whole blood centrifugation, or Bone Marrow Aspirate Concentrate, obtained through iliac crest aspiration.Both autologous biologics were targeted directly into the identified musculoskeletal pathology.Main Outcome Measures: The primary endpoint was Responder Status, defined as achieving a Minimal Clinically Important Difference of >2-point reduction on the Numeric Pain Rating Scale at 6 months.Secondary outcomes included systemic disease complexitydefined as a Multiple Diagnosis Profile involving multijoint or bilateral pathology-and the median Time to Clinical Relief to reach MCID.
Results
Higher BMI correlated with increased disease burden.The obese cohort showed a three-fold increase in multiple diagnoses and an 8-week delay in reaching MCID (p 30kg/m 2 independently predicted failure to achieve MCID at 6 months (p < .05),indicating a blunted response to autologous signaling.
Conclusions
This analysis shifts orthobiologics from a joint-centric to a systemic metabolic-phenotypic paradigm.BMI serves as a surrogate for healing capacity rather than a mechanical variable.Correlation between elevated BMI and disease complexity suggests metainflammation antagonizes autologous signaling.These findings mandate physiatrists integrate metabolic optimization into care, addressing host factors to maximize regenerative efficacy and restore function.
Zitieren
APA
Qasem, S., & Ross, M. (2026). Beyond Analgesia: Evaluating the Chondroprotective Potential of Extracorporeal Shockwave Therapy in Knee Osteoarthritis. PM&R, 18(S3). https://doi.org/10.1002/pmrj.68_70259
Vancouver
Qasem S, Ross M. Beyond Analgesia: Evaluating the Chondroprotective Potential of Extracorporeal Shockwave Therapy in Knee Osteoarthritis. PM&R. 2026;18(S3). doi:10.1002/pmrj.68_70259
BibTeX
@article{Qasem2026,
author = {Qasem, Suha and Ross, Marc},
title = {Beyond Analgesia: Evaluating the Chondroprotective Potential of Extracorporeal Shockwave Therapy in Knee Osteoarthritis},
journal = {PM&R},
year = {2026},
volume = {18},
number = {S3},
doi = {10.1002/pmrj.68_70259}
}
EUVIMED